Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
HLK Biotec Holding Group Inc | 920.0 | --- | --- |
Cantabio Pharmaceuticals Inc | 22.8K | 0.0x | --- |
Regnum Corp | 20.0 | 0.0x | --- |
FutureWorld Corp | 5.2K | 0.0x | --- |
Rebus Holdings Inc | 30.0 | 0.0x | --- |
IR BioSciences Holdings Inc | 20.0 | 0.0x | --- |
HLK Biotec Holding Group, Inc. is a holding company. The Company operates through its China-based subsidiaries, focused on the health industry, research and development (R&D) of high technology (high-tech) health food, healthcare supplies, and low carbon environmental protection. The Company’s wholly owned subsidiary is HLK(Nanjing) Health Food, Co., Ltd.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $920.00 |
---|---|
Revenue (TTM) | --- |
Shares Outstanding | 4.6M |
HLK Biotec Holding Group Inc does not pay a dividend. | |
Beta | 2.55 |
EPS | --- |
Book Value | --- |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.